Delivery Order SPE2DB22D9239-SPE2DB23FDM53
Award Date 9/6/23
Potential Completion Date 9/27/23
Potential Value $73K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at seventy-two thousand eight hundred forty-eight dollars and thirty cents ($72,848.30) to DMS Pharmaceutical Group Inc. to supply twenty thousand (20,000) units of XENPOZYME 20 MG VIALS. Performance will take place in Park Ridge, Illinois under a start date of August 2, 2023 and end date of August 23, 2023. As a key logistics combat support agency within the Department of Defense, the Defense Logistics Agency...
- The Defense Logistics Agency (DOD) awarded a $72,848.30 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 4562136277 units of the drug XENPOZYME in 20 mg vials. The place of performance is Park Ridge, Illinois. The period of performance is from August 30, 2023 through September 21, 2023. No subcontractors or set aside designations were identified. The DLA supports military readiness by procuring and providing logistics support for medical supplies, likely indicating this...
- The Defense Logistics Agency awarded a $73,000 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 4562369675 XENPOZYME 20 MG VIALS. The single award delivery order was issued against an unspecified governmentwide acquisition contract vehicle and will be performed in Park Ridge, Illinois through October 19, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency supports America's armed forces by delivering critical supplies such...
- The Defense Logistics Agency (DOD) awarded a $72,848 delivery order to DMS Pharmaceutical Group Inc. for 4561567690 XENPOZYME 20 MG VIALS. The firm fixed price order has a period of performance from July 13, 2023 through August 3, 2023, with all work to be completed at the prime contractor's facility located in Park Ridge, Illinois. No set aside designation or subcontracting details were provided. The DLA supports military readiness by procuring and providing logistics support for medical...
- The Defense Logistics Agency (DOD) awarded a $72,848.30 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 4561819527 XENPOZYME 20 MG VIALS. The place of performance is Park Ridge, Illinois. The period of performance is from August 3, 2023 through August 24, 2023. As the DLA supports military operations by procuring and providing logistics support for spare parts, supplies, and equipment, this delivery order is likely fulfilling a medical supply requirement to support...
- The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a $72,848 delivery order contract to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. Under the firm fixed price contract, DMS will provide 4562192625 units of 20 mg vials of XENPOZYME pharmaceutical product to the DLA. Performance will take place at the contractor's facility in Park Ridge and span from September 1st through September 25th, 2023. No subcontractors or set aside...
- <p>The Defense Logistics Agency awarded a $72,848.30 firm fixed price delivery order to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The order is for 20 mg vials of Xenpozyme, with performance to be completed by November 6, 2023. DMS Pharmaceutical Group Inc. will deliver the requested Xenpozyme products to the Defense Logistics Agency. No set-aside provision was specified for this award made under an unidentified contracting vehicle.</p>
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at seventy-two thousand eight hundred forty-eight dollars and thirty cents ($72,848.30) by the Defense Logistics Agency to provide forty-five hundred sixty-three thousand ten vials of XENPOZYME 20 MG. The place of performance will be Park Ridge, Illinois and all work must be completed by December 18, 2023. As a woman-owned small business, DMS Pharmaceutical Group holds an indefinite delivery contract with the...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at seventy-two thousand eight hundred forty-eight dollars and thirty cents ($72,848.30) by the Defense Logistics Agency to provide forty-five hundred sixty-three thousand one hundred forty vials of XENPOZYME 20 MG. The delivery order was awarded on December 6, 2023 under DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical products...
- The U.S. Defense Logistics Agency has awarded a Firm Fixed Price Delivery Order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of XENPOZYME 20 MG VIALS. The total potential value of the contract is $72,848.40 with a completion date of March 11, 2024. This Delivery Order is issued under DMS Pharmaceutical Group's broader Indefinite Delivery Vehicle contract, 4600082013, with the Defense Logistics Agency's SPE2DB program. This single-award IDV enables the...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB23FDM53Delivery Order
The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a firm fixed price delivery order valued at seventy-two thousand eight hundred forty-eight dollars and thirty cents ($72,848.30) to DMS Pharmaceutical Group Inc. The order is for twenty thousand four hundred (20,400) vials of XENPOZYME, a twenty milligram medication, to be delivered to a facility in Park Ridge, Illinois by September 27, 2023 in support of DLA's medical supply procurement programs. Performance will take place over a three week period concluding at the end of September. No subcontractors or set aside designations were identified.
Generated 12/18/23, 12:32 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $72.8k | 9/6/23 |